Bayer's Medrad nabs Pathway – it's official
This article was originally published in Clinica
Executive Summary
Bayer HealthCare has confirmed that its imaging subsidiary Medrad has acquired Pathway Medical Technologies in a move to strengthen its vascular intervention portfolio.